ANAPTYSBIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $396.7M | $250.5M |
| FY2021 | — | $356.4M | $495.7M |
| FY2022 | — | $262.1M | $71.3M |
| FY2023 | — | $88.1M | $36.0M |
| FY2024 | — | $70.9M | $123.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $396.7M | $250.5M |
| FY2021 | — | $356.4M | $495.7M |
| FY2022 | — | $262.1M | $71.3M |
| FY2023 | — | $88.1M | $36.0M |
| FY2024 | — | $70.9M | $123.1M |